date,title,source
Oct-17-18,"New Research: Key Drivers of Growth for IDT, Live Nation Entertainment, BioDelivery Sciences International, Spero Therapeutics, Aimmune Therapeutics, and Cars  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-01-18,Aimmune Therapeutics to Participate in Upcoming Investor Conferences,Business Wire
Nov-08-18,Aimmune Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Aimmune Therapeutics Announces Third Quarter 2018 Financial Results and Recent Corporate Highlights,Business Wire
Nov-08-18,Aimmune Therapeutics Announces Presentations at 2018 ACAAI Annual Scientific Meeting,Business Wire
Nov-12-18,Nestle raises stake in food allergy drug developer Aimmune,Reuters
Nov-14-18,Are Options Traders Betting on a Big Move in Aimmune Therapeutics (AIMT) Stock?,Zacks
Nov-19-18,Here's Why Aimmune Therapeutics Closed Down 11.2% After Publishing Its &quot;Landmark&quot; Clinical Trial,Motley Fool
Nov-19-18,Peanut Allergy Remedy Offers Both Hope and Risk,Bloomberg
Nov-19-18,Biotech Slides As Investors Digest Results Of Peanut-Allergy Test,Investor's Business Daily
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-30-18,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",Benzinga
Dec-06-18,"Aimmune Therapeutics to Host Investor Symposium on the Future of Treating Peanut Allergy with Leading Expert Allergists on Wednesday, December 12th",Business Wire
Dec-19-18,Aimmune Therapeutics Initiates Phase 3 POSEIDON Trial for Treatment of Peanut Allergy in 13-Year-Old Children,Business Wire
Dec-20-18,"Why Tilray, Fortuna Silver Mines, and Aimmune Therapeutics Jumped Today",Motley Fool
Dec-20-18,These 4 Biotech Stocks are Picking Up Speed,ACCESSWIRE
Dec-20-18,Delay for Peanut Allergy Drug Sinks Biotech Stock,Bloomberg
Dec-20-18,Sell-Side Slashes DBV Tech Price Targets After Withdrawal Of BLA For Peanut Allergy Immunotherapy,Benzinga
Dec-20-18,Aimmune Therapeutics Announces IND Filing for AR201 for Egg Allergy and Exclusive Supply Agreement with Michael Foods,Business Wire
Dec-20-18,Today's Research Reports on Trending Tickers: Aimmune Therapeutics and FibroGen,ACCESSWIRE
Dec-20-18,[$$] DBV's US-Listed Shares Crash,The Wall Street Journal
Dec-21-18,Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 417,Business Wire
Jan-02-19,"Aimmune Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7th",Business Wire
Jan-03-19,"Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics  Discovering Underlying Factors of Influence",GlobeNewswire
Jan-04-19,Aimmune Therapeutics and KKR Enter into $170M Loan Agreement to Fund AR101 Commercialization and Pipeline Advancement,Business Wire
Jan-08-19,This Under-the-Radar Biotech Stock Is My Top Pick for 2019,TheStreet.com
Jan-14-19,Cramer's lightning round: The way to play Goldman's downgrade of Starbucks,CNBC
Jan-15-19,Today's Research Reports on Trending Tickers: Aimmune Therapeutics and Mirati Therapeutics,ACCESSWIRE
Jan-15-19,"Jim Cramer Shares His Thoughts On Alibaba, Dynavax, Starbucks And More",Benzinga
Jan-18-19,Aimmune Therapeutics Appoints Andrew Oxtoby as Chief Commercial Officer,Business Wire
Jan-22-19,3 Biotech Stocks That Could Be Slapped by the U.S. Government Shutdown,Motley Fool
Feb-01-19,6 Biotech Stocks to Watch Now,Motley Fool
Feb-04-19,"Aimmune Therapeutics to Present AR101, OIT and Peanut Allergy Data at 2019 AAAAI Annual Meeting",Business Wire
Feb-19-19,Trading Notes for Select Stocks,TheStreet.com
Feb-21-19,Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights,Business Wire
Feb-25-19,"Aimmune Therapeutics Presents New AR101 Data at AAAAI, Including Demonstrated Reduction in Accidental Exposures to Peanut Requiring Treatment",Business Wire
Feb-28-19,Aimmune Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Operational Highlights,Business Wire
Mar-05-19,Edited Transcript of AIMT earnings conference call or presentation 28-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-05-19,"Detailed Research: Economic Perspectives on Canopy Growth, Aimmune Therapeutics, Nektar Therapeutics, Workday, Workiva, and MAG Silver  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Mar-05-19,Aimmune Therapeutics to Participate in Three Investor Conferences in March,Business Wire
Mar-07-19,Edited Transcript of AIMT earnings conference call or presentation 28-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-18-19,U.S. FDA Accepts BLA Filing of Aimmune Therapeutics AR101 for Peanut Allergy,Business Wire
Mar-20-19,"NASH, Allergies and Beauty Stocks: Invest or Not?",Zacks
Mar-21-19,"Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus",Zacks
Mar-25-19,Peninsula biotech lines up chance to crack the peanut allergy nut,American City Business Journals
Mar-25-19,European Phase 3 Trial of Aimmune Therapeutics AR101 Meets Primary Endpoint,Business Wire
Apr-03-19,Aimmune Therapeutics to Present at 18th Annual Needham & Company Healthcare Conference,Business Wire
May-01-19,Aimmune Therapeutics to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights,Business Wire
May-02-19,Heres What Hedge Funds Think About Aimmune Therapeutics Inc (AIMT),Insider Monkey
May-08-19,Aimmune Therapeutics: 1Q Earnings Snapshot,Associated Press
May-08-19,Aimmune Therapeutics Announces First Quarter 2019 Financial Results and Provides Operational Highlights,Business Wire
